E-raamat: Establishment of Cancer Gene Therapy

Jerzy Trojan

Formaat: 165 pages
Ilmumisaeg: 17-Feb-2023
Kirjastus: Cambridge Scholars Publishing
ISBN-13: 9781527593909

Teised raamatud teemal:

Formaat - PDF+DRM
Hind: 126,09 €*
* hind on lõplik, st. muud allahindlused enam ei rakendu
Lisa ostukorvi
Lisa soovinimekirja
See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

Formaat: 165 pages
Ilmumisaeg: 17-Feb-2023
Kirjastus: Cambridge Scholars Publishing
ISBN-13: 9781527593909

Teised raamatud teemal:

DRM piirangud

Kopeerimine (copy/paste):

ei ole lubatud
Printimine:

ei ole lubatud
Kasutamine:

Digitaalõiguste kaitse (DRM)
Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

Vajalik tarkvara
Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

Seda e-raamatut ei saa lugeda Amazon Kindle's.

This book describes a 40-year research battle against cancer and, more specifically, glioblastoma, one of the most fatal brain tumours. Using different immunological strategies to fight this disease, the author was able to finally establish a revolutionary and successful treatment based principally on molecular biology named Cancer Gene Therapy. Although this cancer immuno-gene therapy was proposed as an experimental technique back in 1993, clinical results were not fully demonstrated until the 2005-2020s. This therapy can be summarized as follows: after arrest in cancer cells of the principal cancer growth factor IGF-I, using anti-gene IGF-I technology (antisense and triple helix), cells become immunogenic vaccines. Vaccination of glioblastoma patients induces an immune anti-tumour response, allowing an increase in median survival up to two years and a better quality of life.

Jerzy Trojan completed his Dr d'Etat čs Sciences (HDR) at the Sorbonne. He is the author of around 350 publications, including 130 articles, 90 book chapters, and two books. He is also an elected member of the French Academy of Medicine (ANM).

Lisainfo e-raamatute kohta